Medaka fish, Oryzias latipes, as a model for human obesity-related glomerulopathy

https://doi.org/10.1016/j.bbrc.2013.01.053Get rights and content

Abstract

Obesity, an ongoing significant public health problem, is a part of complex disease characterized as metabolic syndrome. Medaka and zebrafish are useful aquatic experimental animals widely used in the field of toxicology and environmental health sciences and as a human disease models. In medaka, simple feeding of a high fat diet (HFD) can induce body weight gain, excessive accumulation of visceral adipose tissue, hyperglycemia, hyperlipidemia, and steatohepatitis, which mimics human metabolic syndrome. In the present study, to explore the possibility that the adult medaka fed with HFD (HFD-medaka) can be used as an animal model for human metabolic syndrome-associated glomerular disease, including obesity-related glomerulopathy (ORG), we analyzed structural alterations and protein expression in the mesonephric kidney of HFD-medaka. We found that the histopathology was consistent with glomerulomegaly accompanied by the dilation of glomerular capillaries and proliferative expansion of the mesangium, a condition partially comparable to human ORG. Moreover, expressions of several kinds of kidney disease-related proteins (such as MYH9, SM22α) were significantly elevated. Thus, the HFD-medaka has a high potential as an animal model useful for exploring the mechanism underling human ORG.

Highlights

Medaka fed with a high fat diet (HFD-medaka) mimicked human metabolic syndrome. ► HFD-medaka displayed glomerulomegaly and proliferative mesangial lesion. ► Several renal disease-related proteins were up-regulated in HFD-medaka kidney. ► HFD-medaka can be used as an animal model for human obesity-related glomerulopathy.

Introduction

Medaka, Oryzias latipes, is a freshwater fish native to East Asian countries, primarily Japan, Korea, China, and Taiwan. This small fish is one of the most useful aquatic experimental animals due to its completely sequenced genome, high fecundity, transparency of embryos, and adaptation to a wide range of temperatures [1]. As in zebrafish, researchers can manipulate gene expression in medaka by the use of forward and reverse genetic techniques, and medaka is also widely used in the fields of developmental biology, toxicology, and environmental health sciences [1], [2], [3].

Recently, it was reported that, in adult medaka, simple feeding of a high fat diet (HFD) could induce body weight gain, excess accumulation of visceral adipose tissue, hyperglycemia and hyperlipidemia (both hypertriglyceridemia and hypercholesterolemia) over a relatively short period. In this condition, medaka adult that are fed HFD (HFD-medaka) consistently exhibit a fatty liver and subsequently develop non-alcoholic steatohepatitis (NASH) [4]. Using this system, several useful drugs for NASH were found [4], [5], [6]. In humans, non-alcoholic fat liver disease followed by NASH initially cause chronic liver dysfunction that may later progress to liver cirrhosis and ultimately hepatocellular carcinoma, and thus new guideline of NASH was developed [7].

Obesity and weight control are ongoing important public health problems. Broadly viewed, obesity may be considered part of a complex disease characterized as obesity-initiated metabolic syndrome, which comprises abdominal obesity, hypertriglyceridemia, low HDL cholesterol, hypertension, and hyperglycemia [8], [9]. The HFD-medaka adult exhibits a variety of similar features consistent with those characteristic seen in human metabolic syndrome, and therefore can be utilized as an informative animal model for the disease. Metabolic syndrome is associated with increased prevalence of chronic kidney disease (CKD), and obesity itself is also known to induce obesity-related glomerulopathy (ORG), which is defined by a combination of obesity, glomerular enlargement (glomerulomegaly), and proteinuria with or without nephrotic state [10], [11], [12], [13]. Kambham and colleagues (2001) reported that ORG patients were all associated with glomerulomegaly [14]. Two histological types were identified: glomerulomegaly with or without focal segmental glomerulosclerosis (FSGS), a pathological feature characterized by partial scarring of the glomerular structure.

In the present study, to explore the potential of the HFD-medaka as an animal model for human metabolic syndrome-associated glomerular disease including ORG, we analyzed the histopathology and protein expression in the mesonephric kidney of HFD-medaka. We found these fish demonstrated characteristic histopathology partially compatible to human ORG. Moreover, the expression of several kidney-disease-related proteins were significantly elevated. We thus present the HFD-medaka adult as a new animal model to study human ORG.

Section snippets

Fish maintenance

Medaka (Cab strain) were maintained and raised at 28.5 °C under a 14-h light/10-h dark cycle. Each tank was supplied daily with 200 mg of food, which was consumed within 14 h. The energy content of the control diet (Hikari Crest; Kyorin, Hyogo, Japan) was 3.3 kcal/g with 25.3% from fat, 62.5% from protein and 3.8% from carbohydrates. The energy content of the HFD (HFD32; CLEA Japan, Tokyo, Japan) was 5.1 kcal/g with 56.7% from fat, 20.1% from protein and 23.2% from carbohydrates [4]. Experiments

Blood glucose level in the HFD-medaka

To confirm an alteration of metabolic condition in the HFD-medaka, we examined blood glucose level. Diet manipulation was initiated in medaka adult at 8 weeks of age. In control medaka, blood glucose levels measured at 4, 8, and 12 weeks later returned values of 105 ± 7, 90 ± 8, and 92 ± 18 mg/dl, respectively (n = 10 in each group) (Fig. 1A). In HFD-medaka, blood glucose level was elevated already at 4 weeks after diet initiation (160 ± 74 mg/dl), and sustained at 8 and 12 weeks (177 ± 62, and 173 ± 58 mg/dl,

Discussion

The HFD-medaka mimics several features of the human metabolic syndrome, which is characterized by a combination of abdominal obesity, hypertriglyceridemia, low level of HDL cholesterol, hypertension, and hyperglycemia. All of these components except for hypertension were recognized in the HFD-medaka, as previously reported [4], [5], [6]. Several kinds of glomerular disease can be induced in metabolic syndrome patients, including diabetes nephropathy, FSGS, and ORG. In the present study, the

Acknowledgment

The authors thank Dr. Deborah Garrity for helpful criticism and comments on the manuscript. T.O. acknowledges financial support from the University of Oklahoma Health Sciences Center (OUHSC). K.I. was supported by Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (No. 23590226). Y. Kawashima was supported by Grant-in-Aid for JSPS Fellows (23-10925). T.O. was supported by NIH grants R21-DK069604, and R01-DK078209.

References (46)

  • Y. Ishikawa

    Medaka fish as a model system for vertebrate developmental genetics

    Bioessays

    (2000)
  • T. Matsumoto et al.

    Medaka as a model for human nonalcoholic steatohepatitis

    Dis. Model Mech.

    (2010)
  • S. Kuwashiro et al.

    Telmisartan improves nonalcoholic steatohepatitis in medaka (Oryzias latipes) by reducing macrophage infiltration and fat accumulation

    Cell Tissue Res.

    (2011)
  • N. Chalasani et al.

    The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

    Hepatology

    (2012)
  • E.S. Ford et al.

    Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

    JAMA

    (2002)
  • S.P. Bagby

    Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?

    J. Am. Soc. Nephrol.

    (2004)
  • I.M. Wahba et al.

    Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease

    Clin. J. Am. Soc. Nephrol.

    (2007)
  • J.R. Weisinger et al.

    The nephrotic syndrome: a complication of massive obesity

    Ann. Intern. Med.

    (1974)
  • Y. Wu et al.

    Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples

    Endocrinology

    (2006)
  • K. Ichimura et al.

    Structural disorganization of pronephric glomerulus in zebrafish mpp 5a/nagie oko mutant

    Dev. Dyn.

    (2012)
  • H.W. Smith

    Comparative Physiology of the Kidney

  • J.C. Jennette et al.

    Heptinstall′s pathology of the kidney

    (2007)
  • B.L. Kasiske et al.

    Renal disease in patients with massive obesity

    Arch. Intern. Med.

    (1986)
  • Cited by (0)

    1

    These authors contributed equally to this work.

    View full text